India's Piramal Group chairman discusses the investment in its pharma business from Carlyle Group

Ajay Piramal, chairman of Piramal Group, describes the deal with Carlyle Group as the largest equity investment by any private equity firm in India's pharmaceutical sector, and explains his outlook for the health care sector in the aftermath of the coronavirus pandemic.
Tue, Jun 30 20205:29 AM EDT